Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


This article is a clinical case study of a 47-years old woman with mild-symptoms that resolved without treatment after 10 days. She was tested positive for SARS-COV2 by RT-qPCR at day 4, 5,6, time after which the virus was undetectable. Phenotyping by flow cytometry of immune cells from blood shows increased circulating TFH (CD4+CXCR5+PD1+ICOS+), antibody-secreting cells (CD19+CD27hiCD38hi) and activated CD8+ and CD4+ T cells (CD38+HLADR+) at day 7,8,9 that persist at day 20. In the serum, the presence of SARS-COV2 specific IgG and IgM was detected by immunofluorescence staining of SARS-COV2 infected Vero cells. These results suggest that primary anti-viral B and T cell response occur in this patient and might correlate with better outcome.


  • Presence of B cell response after infection with increased ASC and cTFH in blood
  • SARS-COV2 specific IgM and IgG detected in plasma
  • Presence of anti-viral CD8+ T cell response after infection that is still not contracted one-week post-symptoms


They suggest some parameters that could be used in a larger cohort of patients with different disease severities to test if they could predict the disease outcome.


Case study-one patient



  • They provide the gating strategy
  • They analyse the blood of this patient at different time-points during and after the presence of the symptoms.


  • It remains anecdotal as it includes a single patient and it would be very interested to look at similar parameters on a bigger cohort as suggested by the authors.
  • This study looks at the presence of IgG and IgM but they don’t titer the Ab response that could be important to highlight an efficient B cell response.
  • Even if the authors look 20 days after the initial symptoms, it remains too early to look at the formation of memory.